173 related articles for article (PubMed ID: 375448)
1. Immunotherapy of solid tumor.
Holmes EC
Surg Clin North Am; 1979 Apr; 59(2):371-80. PubMed ID: 375448
[No Abstract] [Full Text] [Related]
2. Immunotherapy from malignant disease.
Goodnight JE; Morton DL
Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
[No Abstract] [Full Text] [Related]
3. BCG, levamisole and transfer factor in the treatment of cancer.
Spitler LE
Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
[No Abstract] [Full Text] [Related]
4. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Mathe G
Comp Immunol Microbiol Infect Dis; 1980; 3(4):407-32. PubMed ID: 6451350
[No Abstract] [Full Text] [Related]
5. Immunotherapy of cancer.
Holmes EC; Morton DL; Eilber FR
West J Med; 1977 Feb; 126(2):102-9. PubMed ID: 322390
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant immunotherapy.
Goodnight JE; Morton DL
Int Adv Surg Oncol; 1978; 1():53-83. PubMed ID: 399764
[TBL] [Abstract][Full Text] [Related]
7. [Current trends in immunotherapy of tumors of the lung].
Crispano G; Toglia V; Tranchese D; Schettini R
Arch Monaldi; 1983; 38(1-2):41-52. PubMed ID: 6675558
[No Abstract] [Full Text] [Related]
8. [Current status of immunotherapy of malignant tumors].
Flad HD; Betzler M; Herfarth C
Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730
[No Abstract] [Full Text] [Related]
9. Hepatic granulomas and other hepatic lesions associated with BCG immunotherapy for cancer.
Bodurtha A; Kim YH; Laucius JF; Donato RA; Mastrangelo MJ
Am J Clin Pathol; 1974 Jun; 61(6):747-52. PubMed ID: 4598826
[No Abstract] [Full Text] [Related]
10. Immunotherapy of cancer in man.
Carter SK
Am Sci; 1976; 64(4):418-23. PubMed ID: 786091
[No Abstract] [Full Text] [Related]
11. Adjuvant therapy for melanoma.
Sondak VK; Wolfe JA
Curr Opin Oncol; 1997 Mar; 9(2):189-204. PubMed ID: 9161800
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy of breast cancer (review of foreign literature)].
Liapis MA
Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
[No Abstract] [Full Text] [Related]
13. Current state of clinical immunotherapy.
Woodruff MF
Transplant Proc; 1979 Mar; 11(1):1077-81. PubMed ID: 377611
[No Abstract] [Full Text] [Related]
14. [Comparison of two nonspecific immune stimuli in antiblastic chemotherapy].
Bianucci P; Pastorino G
Arch Sci Med (Torino); 1980; 137(1):33-40. PubMed ID: 7458652
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy of cutaneous malignant melanoma: a critical review.
Koh HK; Sober AJ; Harmon DC; Lew RA; Carey RW
Med Pediatr Oncol; 1985; 13(5):244-60. PubMed ID: 3897817
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment of rodent fibrosarcoma by radiotherapy and immune adjuvant.
Moroson H; Rotman M; Schechter M
Int J Radiat Oncol Biol Phys; 1976; 1(3-4):267-74. PubMed ID: 786964
[No Abstract] [Full Text] [Related]
17. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
18. Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types.
Mikulski SM; McGuire WP; Louie AC; Chirigos MA; Muggia FM
Cancer Treat Rev; 1979 Sep; 6(3):177-90. PubMed ID: 394836
[No Abstract] [Full Text] [Related]
19. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy of malignant diseases. A way towards the goal?].
Riethmüller G
MMW Munch Med Wochenschr; 1978 Feb; 120(6):161-2. PubMed ID: 305530
[No Abstract] [Full Text] [Related]
[Next] [New Search]
